Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
<p><strong>Objectives</strong></p><p>Treat to target recommendations for PsA state that the target of treatment should be remission or, at the very least, low disease activity. Different clinical indexes have been proposed to define these disease states including the mi...
Hlavní autoři: | Coates, L, Rahman, P, Psaradellis, E, Rampakakis, E, Osborne, B, Lehman, A, Nantel, F |
---|---|
Médium: | Journal article |
Vydáno: |
Oxford University Press
2018
|
Podobné jednotky
-
Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
Autor: Emmanouil Rampakakis, a další
Vydáno: (2020-08-01) -
Golimumab for the treatment of psoriatic arthritis
Autor: H Yang, a další
Vydáno: (2011-05-01) -
Golimumab in the treatment of psoriatic arthritis: efficacy and safety
Autor: Tatiana Viktorovna Korotaeva, a další
Vydáno: (2015-09-01) -
Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
Autor: Proton Rahman, a další
Vydáno: (2020-09-01) -
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
Autor: M. Rossini, a další
Vydáno: (2015-03-01)